$ALDR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALDER BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALDER BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in ALDER BIOPHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Campoy Carlos | Chief Financial Off ... | Option Exercise | D | 11.50 | 270,000 | 3,105,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | STRECK PAUL | Chief Medical Offic ... | Option Exercise | D | 13.41 | 250,000 | 3,352,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | STRECK PAUL | Chief Medical Offic ... | Sell | D | 18.00 | 1,390 | 25,020 | 0 | 1.4 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | STRECK PAUL | Chief Medical Offic ... | Grant | A | 9.20 | 1,390 | 12,788 | 1,390 | 0 to 1.4 K |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Dac Nadia | Chief Commercial Of ... | Option Exercise | D | 13.90 | 250,000 | 3,475,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | D | 13.20 | 30,000 | 396,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | U | 0.00 | 20,243 | 0 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | D | 188.64 | 54,757 | 10,329,360 | 20,243 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | X | 0.00 | 75,000 | 0 | 75,000 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | X | 137.88 | 75,000 | 10,341,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | J | 137.88 | 75,000 | 10,341,000 | 75,000 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | U | 0.00 | 779,776 | 0 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Sell | U | 0.00 | 8,244,896 | 0 | 0 | 8.2 M to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Lavelle Erin | Chief Operating Off ... | Option Exercise | D | 14.00 | 150,000 | 2,100,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Lavelle Erin | Chief Operating Off ... | Option Exercise | D | 14.55 | 300,000 | 4,365,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Lavelle Erin | Chief Operating Off ... | Sell | U | 18.00 | 16,092 | 289,656 | 0 | 16.1 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Lavelle Erin | Chief Operating Off ... | Grant | A | 0.00 | 11,684 | 0 | 16,092 | 4.4 K to 16.1 K (+265.06 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Option Exercise | D | 14.00 | 135,000 | 1,890,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Option Exercise | D | 13.24 | 70,000 | 926,800 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Option Exercise | D | 13.55 | 70,000 | 948,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Option Exercise | D | 10.70 | 35,000 | 374,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Option Exercise | D | 20.40 | 50,000 | 1,020,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Option Exercise | D | 20.17 | 95,000 | 1,916,150 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Sell | U | 18.00 | 27,677 | 498,186 | 0 | 27.7 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Grant | A | 0.00 | 15,619 | 0 | 27,677 | 12.1 K to 27.7 K (+129.53 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Grant | A | 9.20 | 904 | 8,317 | 12,058 | 11.2 K to 12.1 K (+8.10 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Grant | A | 9.20 | 1,345 | 12,370 | 11,154 | 9.8 K to 11.2 K (+13.71 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | D | 14.00 | 150,000 | 2,100,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | D | 13.55 | 80,000 | 1,084,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | D | 10.70 | 60,000 | 642,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | D | 20.40 | 60,000 | 1,224,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | D | 24.18 | 75,000 | 1,813,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | D | 28.23 | 30,000 | 846,900 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | D | 11.79 | 80,000 | 943,200 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Sell | D | 18.00 | 19,780 | 356,040 | 0 | 19.8 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Grant | A | 0.00 | 14,346 | 0 | 19,780 | 5.4 K to 19.8 K (+264.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 14.00 | 100,000 | 1,400,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 13.55 | 60,000 | 813,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 10.70 | 50,000 | 535,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 20.40 | 85,000 | 1,734,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 24.18 | 100,000 | 2,418,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 28.23 | 50,000 | 1,411,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 16.90 | 35,000 | 591,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 10.00 | 13,636 | 136,360 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 6.77 | 13,636 | 92,248 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 3.47 | 31,818 | 110,249 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | D | 3.47 | 17,271 | 59,844 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | D | 18.00 | 21,502 | 387,036 | 0 | 21.5 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Grant | A | 0.00 | 16,230 | 0 | 21,502 | 5.3 K to 21.5 K (+307.85 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | YARNO WENDY L | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | YARNO WENDY L | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | YARNO WENDY L | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | YARNO WENDY L | Director | Option Exercise | D | 19.75 | 30,000 | 592,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | YARNO WENDY L | Director | Sell | U | 18.00 | 5,000 | 90,000 | 0 | 5 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 39.66 | 6,350 | 251,841 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 6.33 | 6,363 | 40,246 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 3.96 | 6,363 | 25,197 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | D | 4.46 | 6,363 | 28,347 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Sell | U | 18.00 | 31,714 | 570,852 | 0 | 31.7 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Preston Heather | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Preston Heather | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Preston Heather | Director | Option Exercise | D | 39.66 | 6,350 | 251,841 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 39.66 | 6,350 | 251,841 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 6.33 | 6,363 | 40,246 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 3.47 | 6,363 | 22,048 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | D | 3.96 | 12,727 | 50,399 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Sell | U | 18.00 | 9,628 | 173,304 | 0 | 9.6 K to 0 (-100.00 %) |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 11.95 | 100,000 | 1,195,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 32.76 | 17,300 | 566,748 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | D | 38.54 | 12,700 | 489,458 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 11.01 | 22,500 | 247,725 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 15.50 | 15,000 | 232,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 16.90 | 15,000 | 253,500 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 29.26 | 15,000 | 438,900 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | D | 31.10 | 30,000 | 933,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | D | 16.20 | 150,000 | 2,430,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | D | 0.00 | 15,000 | 0 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | D | 14.00 | 505,000 | 7,070,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | D | 16.20 | 1,000,000 | 16,200,000 | 0 | |
Oct 24 2019 | ALDR | ALDER BIOPHARMACEU ... | H LUNDBECK A S | 10% Owner | Buy | P | 0.00 | 85,923,561 | 0 | 0 | -85,923,561 to 0 (-100.00 %) |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 3.47 | 10,001 | 34,653 | 17,271 | |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 3.47 | 10,001 | 34,653 | 17,271 | |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 4.46 | 22,727 | 101,249 | 0 | |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 4.46 | 22,727 | 101,249 | 0 | |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | S | 18.44 | 32,728 | 603,504 | 5,272 | 38 K to 5.3 K (-86.13 %) |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | S | 18.44 | 32,728 | 603,504 | 5,272 | 38 K to 5.3 K (-86.13 %) |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 3.47 | 10,001 | 34,653 | 38,000 | 28 K to 38 K (+35.72 %) |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 3.47 | 10,001 | 34,653 | 38,000 | 28 K to 38 K (+35.72 %) |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 4.46 | 22,727 | 101,249 | 27,999 | 5.3 K to 28 K (+431.09 %) |
Sep 18 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 4.46 | 22,727 | 101,249 | 27,999 | 5.3 K to 28 K (+431.09 %) |
Jul 01 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | A | 0.00 | 19,023 | 0 | 779,776 | |
May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | YARNO WENDY L | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | SIEGALL CLAY B | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | Montgomery Alan Bruce | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | Carter Paul Rutherford | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
May 28 2019 | ALDR | ALDER BIOPHARMACEU ... | Cleveland Paul B | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
May 24 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | A | 11.01 | 22,500 | 247,725 | 22,500 | |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | A | 16.20 | 150,000 | 2,430,000 | 150,000 | |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Sell | S | 13.85 | 1,738 | 24,067 | 5,434 | 7.2 K to 5.4 K (-24.23 %) |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Grant | A | 0.00 | 7,172 | 0 | 7,172 | 0 to 7.2 K |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Sell | S | 13.65 | 1,734 | 23,662 | 39,728 | 41.5 K to 39.7 K (-4.18 %) |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Grant | A | 0.00 | 7,055 | 0 | 41,462 | 34.4 K to 41.5 K (+20.50 %) |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | D | 13.73 | 4,847 | 66,526 | 5,272 | 10.1 K to 5.3 K (-47.90 %) |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Grant | A | 0.00 | 9,288 | 0 | 10,119 | 831 to 10.1 K (+1,117.69 %) |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Lavelle Erin | Chief Operating Off ... | Sell | S | 13.67 | 1,434 | 19,599 | 4,408 | 5.8 K to 4.4 K (-24.55 %) |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Lavelle Erin | Chief Operating Off ... | Grant | A | 0.00 | 5,842 | 0 | 5,842 | 0 to 5.8 K |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Sell | S | 13.85 | 1,897 | 26,281 | 9,809 | 11.7 K to 9.8 K (-16.21 %) |
Apr 25 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Grant | A | 0.00 | 7,810 | 0 | 11,706 | 3.9 K to 11.7 K (+200.46 %) |
Apr 10 2019 | ALDR | ALDER BIOPHARMACEU ... | Dac Nadia | Chief Commercial Of ... | Option Exercise | A | 13.90 | 250,000 | 3,475,000 | 250,000 | |
Mar 06 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Grant | A | 11.50 | 1,739,130 | 19,999,995 | 8,244,896 | 6.5 M to 8.2 M (+26.73 %) |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | A | 14.00 | 100,000 | 1,400,000 | 100,000 | |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Lavelle Erin | Chief Operating Off ... | Option Exercise | A | 14.00 | 150,000 | 2,100,000 | 150,000 | |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | A | 14.00 | 160,000 | 2,240,000 | 160,000 | |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Grant | A | 9.35 | 487 | 4,553 | 244,180 | 243.7 K to 244.2 K (+0.20 %) |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Hassler Randal | EVP, Pharmaceutical ... | Option Exercise | A | 14.00 | 150,000 | 2,100,000 | 150,000 | |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Option Exercise | A | 14.00 | 135,000 | 1,890,000 | 135,000 | |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | EVP & General Couns ... | Grant | A | 9.35 | 273 | 2,553 | 3,896 | 3.6 K to 3.9 K (+7.54 %) |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Option Exercise | A | 14.00 | 100,000 | 1,400,000 | 100,000 | |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Grant | A | 9.35 | 954 | 8,920 | 34,407 | 33.5 K to 34.4 K (+2.85 %) |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Benedict Larry | EVP and PAO | Grant | A | 9.35 | 1,319 | 12,333 | 33,453 | 32.1 K to 33.5 K (+4.10 %) |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Feb 08 2019 | ALDR | ALDER BIOPHARMACEU ... | Azelby Robert | President and CEO | Option Exercise | A | 14.00 | 505,000 | 7,070,000 | 505,000 | |
Jan 23 2019 | ALDR | ALDER BIOPHARMACEU ... | STRECK PAUL | Chief Medical Offic ... | Option Exercise | A | 13.42 | 250,000 | 3,355,000 | 250,000 | |
Jan 03 2019 | ALDR | ALDER BIOPHARMACEU ... | Redmile Group, LLC | Director | Option Exercise | J | 0.00 | 18,558 | 0 | 760,753 | |
Dec 14 2018 | ALDR | ALDER BIOPHARMACEU ... | Campoy Carlos | Chief Financial Off ... | Option Exercise | A | 11.50 | 270,000 | 3,105,000 | 270,000 | |
Dec 04 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 0.99 | 5,044 | 4,994 | 0 | |
Dec 04 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | S | 13.84 | 5,044 | 69,826 | 831 | 5.9 K to 831 (-85.86 %) |
Dec 04 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 0.99 | 5,044 | 4,994 | 5,875 | 831 to 5.9 K (+606.98 %) |
Nov 27 2018 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | Sr. VP & General Co ... | Option Exercise | A | 13.24 | 70,000 | 926,800 | 70,000 | |
Nov 27 2018 | ALDR | ALDER BIOPHARMACEU ... | Bucher James B | Sr. VP & General Co ... | Grant | A | 9.35 | 2,000 | 18,700 | 3,623 | 1.6 K to 3.6 K (+123.23 %) |
Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Option Exercise | M | 0.99 | 5,040 | 4,990 | 5,044 | |
Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Sell | S | 13.42 | 5,040 | 67,637 | 831 | 5.9 K to 831 (-85.85 %) |
Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Smith Jeffrey T L | Managing Director | Buy | M | 0.99 | 5,040 | 4,990 | 5,871 | 831 to 5.9 K (+606.50 %) |
Nov 05 2018 | ALDR | ALDER BIOPHARMACEU ... | Latham John A | Chief Scientific Of ... | Option Exercise | M | 10.00 | 18,181 | 181,810 | 0 |